BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30884782)

  • 1. What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.
    Leung AWY; Amador C; Wang LC; Mody UV; Bally MB
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30884782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal Formulations in Clinical Use: An Updated Review.
    Bulbake U; Doppalapudi S; Kommineni N; Khan W
    Pharmaceutics; 2017 Mar; 9(2):. PubMed ID: 28346375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicines for the Delivery of Biologics.
    Wahlich J; Desai A; Greco F; Hill K; Jones AT; Mrsny RJ; Pasut G; Perrie Y; Seib FP; Seymour LW; Uchegbu IF
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31058802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems.
    Spyratou E; Mourelatou EA; Makropoulou M; Demetzos C
    Expert Opin Drug Deliv; 2009 Mar; 6(3):305-17. PubMed ID: 19327046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharma business models in Canada.
    March-Chordà I; Yagüe-Perales RM
    Drug Discov Today; 2011 Aug; 16(15-16):654-8. PubMed ID: 21708279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sticking to the knitting: CIHR, innovation and Canadian biotech.
    Edelson J
    Healthc Q; 2005; 8(3):65-8. PubMed ID: 16078405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.
    MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal formulations for inhalation.
    Cipolla D; Gonda I; Chan HK
    Ther Deliv; 2013 Aug; 4(8):1047-72. PubMed ID: 23919478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study of the Impact of Internet-Based Instruction Integrated Innovation Education on University Student Entrepreneurial Team Collaboration and Strategic Innovation.
    Zhao D; Zhong H; Wu Y; Zhou Q
    Front Psychol; 2020; 11():1264. PubMed ID: 32670149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring hot flashes: summary of a National Institutes of Health workshop.
    Miller HG; Li RM
    Mayo Clin Proc; 2004 Jun; 79(6):777-81. PubMed ID: 15182093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enabling health technology innovation in Canada: Barriers and facilitators in policy and regulatory processes.
    MacNeil M; Koch M; Kuspinar A; Juzwishin D; Lehoux P; Stolee P
    Health Policy; 2019 Feb; 123(2):203-214. PubMed ID: 30352755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of liposomal amphotericin B formulation.
    Gulati M; Bajad S; Singh S; Ferdous AJ; Singh M
    J Microencapsul; 1998; 15(2):137-51. PubMed ID: 9532520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics.
    du Plessis LH; Marais EB; Mohammed F; Kotzé AF
    Curr Pharm Biotechnol; 2014; 15(7):659-72. PubMed ID: 25091118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian community health centres and the Internet: exploring the challenges and solutions.
    Jamieson R
    Clin Perform Qual Health Care; 1997; 5(2):76-80. PubMed ID: 10167216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers.
    Gardikis K; Tsimplouli C; Dimas K; Micha-Screttas M; Demetzos C
    Int J Pharm; 2010 Dec; 402(1-2):231-7. PubMed ID: 20934501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.